FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely to ophthalmology, and can be applied as reparative and regenerative ophthalmological medication. Eye drops represent combined medication based on taurine and polymer of dextran or copolymer N-vinylpyrrolidone with 2-methyl-5-vinylpyridine, which contains nicotinamide, nipagin, sodium chloride, potassium monophosphate, sodium diatomic phosphate and water with definite component ratio, for treatment of dystrophic diseases and traumas of eye tissues: stimulator of reparative processes in case of senile, diabetic, radial and traumatic cataracts; in prevention and treatment of cornea lesions; treatment of hereditary cornea dystrophy.
EFFECT: invention ensures increase of medication efficiency and reduction of instillation quantity.
3 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES RELATED TO EYE TISSUE METABOLIC DISEASE AND INFLAMMATORY EYE TISSUE INJURY | 2013 |
|
RU2521337C1 |
EYE DROPS | 2012 |
|
RU2504372C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF GEL FOR TREATING METABOLIC INVOLVEMENTS OF OCULAR TISSUES | 2014 |
|
RU2575558C1 |
DISULFIRAM AND TAURINE-CONTAINING OPHTHALMOLOGICAL MEDICATION IN FORM OF EYE DROPS | 2012 |
|
RU2485939C1 |
OCULAR DROPS WITH REPARATIVE AND ANTI-GLAUCOMA ACTION | 2005 |
|
RU2295331C2 |
COMBINED OPHTHALMIC AGENT | 2019 |
|
RU2733392C1 |
EYE DROPS BASED ON COMPOSITION OF PHARMACEUTICALLY ACCEPTABLE ADDITIVE ACID SALTS AND METHYLETHYL PYRIDONOL AND TAURINE CONTAINING COMPOSITION OF GROUP B VITAMINS | 2013 |
|
RU2533276C1 |
REPARATIVE OPHTHALMIC MEDICINAL COMPOSITION | 2009 |
|
RU2402315C2 |
COMBINED OPHTHALMIC PREPARATION PRESENTED IN FORM OF EYE DROPS AND CONTAINING POLYHEXAMETHYLENE GUANIDINE AND TAURINE | 2012 |
|
RU2513997C1 |
EYE DROPS | 2009 |
|
RU2404768C1 |
Authors
Dates
2011-03-20—Published
2009-12-11—Filed